Gene · 1441
Papers3,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adipocyte- and Monocyte-Mediated Vicious Circle of Inflammation and Obesity (Review of Cellular and Molecular Mechanisms). | Int J Mol Sci | 2023 | 37569635 | PubTator, text mining | PubMed |
| YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells. | Cancers (Basel) | 2023 | 37568827 | PubTator, text mining | PubMed |
| Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds. | Cancers (Basel) | 2023 | 37568796 | PubTator, text mining | PubMed |
| Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. | Cancers (Basel) | 2023 | 37568719 | PubTator, text mining | PubMed |
| Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms. | Cancers (Basel) | 2023 | 37568631 | PubTator, text mining | PubMed |
| The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease. | Cells | 2023 | 37566060 | PubTator, text mining | PubMed |
| TUSC3 Methylation in Peripheral Blood Cells as a Biomarker for Diagnosis of Colorectal Cancer. | Adv Biomed Res | 2023 | 37564442 | PubTator, text mining | PubMed |
| Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37559343 | PubTator, text mining | PubMed |
| Analytical sameness methodology for the evaluation of structural, physicochemical, and biological characteristics of Armlupeg: A pegfilgrastim biosimilar case study. | PLoS One | 2023 | 37556495 | PubTator, text mining | PubMed |
| [Analysis of CSF3R Gene Mutations and Clinical Characteristics in Patients with t(8;21) Acute Myeloid Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 37551471 | PubTator, text mining | PubMed |
| Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37543820 | PubTator, text mining | PubMed |
| SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC. | Aging (Albany NY) | 2023 | 37535001 | PubTator, text mining | PubMed |
| Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC. | Heliyon | 2023 | 37534013 | PubTator, text mining | PubMed |
| Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease. | J Transl Int Med | 2023 | 37533842 | PubTator, text mining | PubMed |
| Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review. | Front Pediatr | 2023 | 37528877 | PubTator, text mining | PubMed |
| Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis. | Sci Rep | 2023 | 37528145 | PubTator, text mining | PubMed |
| Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia? | Ann Hematol | 2023 | 37522967 | PubTator, text mining | PubMed |
| Screening of Potential Circulating Diagnostic Biomarkers and Molecular Mechanisms of Systemic Lupus Erythematosus-Related Myocardial Infarction by Integrative Analysis. | J Inflamm Res | 2023 | 37520666 | PubTator, text mining | PubMed |
| HMGB1, a potential regulator of tumor microenvironment in KSHV-infected endothelial cells. | Front Microbiol | 2023 | 37520371 | PubTator, text mining | PubMed |
| Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37519809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1441/papers?page=17